OCENA KARDIOTOKSYCZNOŚCI TRASTUZUMABU W LECZENIU ADJUWANTOWYM CHORYCH NA HER2 POZYTYWNEGO RAKA PIERSI
Abstract
Author(s): E Staroslawska, A CzerepiÅ?ska, A Chrzanowska-Kapica, A Twardosz Centrum Onkologii Ziemi Lubelskiej, Lublin
OCENA KARDIOTOKSYCZNOŚCI TRASTUZUMABU W LECZENIU ADJUWANTOWYM CHORYCH NA HER2 POZYTYWNEGO RAKA PIERSI
Share this article
Editors List
-
S.SREEDHAR
Submitted PhD thesis in Biotechnology at GITAM University, Vizag.
-
Yousef Alomi
Yousef Alomi
The Past Head, General Administration of Pharmaceutical Care at Ministry of Health,
Saudi Arabia Critical Care/TPN
Clinical Pharmacist Ministry of Health,
Riyadh, Saudi Arabia. -
Osamu Tanaka
Osamu Tanaka
Assistant Professor,
Department of Radiation Oncology
Asahi University Hospital
Gifu city, Gifu, Japan -
Maher Abdel Fattah Al-Shayeb
Department of Surgical Sciences, Ajman University, UAE
-
Andrzej Zdziennicki
Institute of Gynecology and Obstetrics, Medical University of Lodz, I Clinic of Gynecology and Gynecological Oncology (Lodz, Poland)
Google Scholar citation report
Citations : 61
Onkologia i Radioterapia received 61 citations as per Google Scholar report
Onkologia i Radioterapia peer review process verified at publons
Indexed In
- Scimago
- SCOPUS
- MIAR
- Euro Pub
- Google Scholar
- Medical Project Poland
- PUBMED
- Cancer Index
- Gdansk University of Technology, Ministry Points 20